IBB - iShares Biotechnology ETF

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
+0.25 (+0.20%)
At close: 04:00PM EDT
127.10 +0.01 (+0.01%)
After hours: 06:51PM EDT
Stock chart is not supported by your current browser
Previous Close126.84
Bid127.00 x 1300
Ask127.25 x 900
Day's Range126.32 - 127.56
52 Week Range104.29 - 138.74
Avg. Volume1,578,485
Net Assets7.93B
PE Ratio (TTM)16.58
YTD Daily Total Return-3.15%
Beta (5Y Monthly)0.75
Expense Ratio (net)0.44%
Inception Date2001-02-05
  • InvestorPlace

    The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

    Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance. No matter what’s going on in the economy, scientists will continue pressing forward for medical innovations. Given the practically limitless opportunities available, this sector enjoys massive pertinence. However, it’s also a volatile arena if you’re choosing individual stocks. While one company ca

  • etf.com

    The Recent Bullish Trend in IBB, XBI Looks Shaky

    Rising interest rates taking steam from rally that powered in IBB and XBI.

  • etf.com

    Subversive Launches ETF to Focus on Mental Health

    The debut highlights the lack of funds focused on the area.

  • etf.com

    Biotech May Offer Compelling Value

    IBB has fallen less than the S&P 500 this year, and may beat again in 2023.

  • GlobeNewswire

    Tarsus Added to NASDAQ Biotechnology Index

    IRVINE, Calif., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that Tarsus will be added to the NASDAQ Biotechnology Index® (NASDAQ: NBI), effective December 19, 2022. The NASDAQ Biotechnology Index is designed to track the performance of a set of biotechnology and pharmaceutical companies listed on T

  • InvestorPlace

    The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market

    These are seven of the best stocks to buy that can see substantial returns in the months ahead. Despite the ongoing worries on Wall Street, seasoned investors realize that there may be a bull market in some segments of the market even during these gloomy weeks. Fears of sticky inflation and recession led to many investors reevaluating their investments or pulling their money out of the stock markets altogether. As a result, the S&P 500 index has dropped 23% year to date, while the tech-heavy NAS

  • InvestorPlace

    The 7 Best Biotech Stocks to Buy

    I’ve written before about how biotech is the biggest technology trend of our kids’ generation. Naturally, that means many people are looking for the best biotech stocks to buy. But as with the PC industry of my time, finding long-term winners is difficult. Back in the early 1980s, dozens of companies entered the PC market, many of them huge for their time. IBM (NYSE:IBM) was the bet everyone made. But the BUNCH — Burroughs, Univac, NCR (NYSE:NCR), Control Data and Honeywell (NASDAQ:HON), were al

  • Yahoo Finance Video

    Market indices clinch gains at the close, meme stocks jump

    Yahoo Finance's Jared Blikre looks at how markets closed on Thursday, with meme stocks and financials leading the way.

  • Yahoo Finance Video

    Stocks mixed as ECB hikes rates, Italy’s Mario Draghi resigns

    Yahoo Finance’s Jared Blikre breaks down how markets opened on Thursday.

  • Zacks

    The Overlooked Difference in June's Inflation Report

    Today's reaction to a high CPI print is the opposite of what we saw last month.

  • Yahoo Finance Video

    Market check: Stocks open mixed, bond yields fall, Tesla stock dips

    Yahoo Finance's Jared Blikre breaks down how markets opened on Wednesday.

  • InvestorPlace

    3 Biotech Stocks to Sell Now

    Biotech stocks have been brought low over the past 18 months. Both the iShares Biotechnology ETF (NASDAQ:IBB) and S&P Biotech ETF (NYSEARCA:XBI), Wall Street’s two most popular funds that track the industry, dropped 33% and 57% since peaking last February. But the losses were worse two weeks ago. Many biotechs rallied back, and both ETFs are sporting double bottom formations. Unfortunately, some components still have broken trends and remain vulnerable to further downside. I scoured the top hold

  • Yahoo Finance Video

    Market check: Stocks open higher, travel stocks gain

    Yahoo Finance’s Jared Blikre breaks down how markets opened on Tuesday.

  • Yahoo Finance Video

    Markets see third-best week of 2022, software stocks among biggest gainers

    Yahoo Finance's Jared Blikre breaks down today's market action, highlighting some of the best-performing sectors. 

  • Yahoo Finance Video

    Market check: Stocks open higher, ARKK extends gains, Russell to rebalance indices

    Yahoo Finance’s Jared Blikre breaks down how markets opened on Friday.

  • Yahoo Finance Video

    Homebuilder stocks lead markets higher, travel stocks in the red

    Yahoo Finance's Jared Blikre joins the Live show to break down how stocks are trading as Fed Chair Powell continues to testify before Congress.

  • Yahoo Finance Video

    Markets see modest gains, small-cap and energy stocks among biggest leaders

    Yahoo Finance's Jared Blikre looks at today's outperformers in the stock market.